Close Menu
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Subscribe
    Home»Top Stories»Bursa Malaysia records 17.4% decrease in Q1 2023 profit on lower trading revenue
    Bursa Malaysia
    Bursa Malaysia
    Top Stories

    Bursa Malaysia records 17.4% decrease in Q1 2023 profit on lower trading revenue

    Aiko AkihiroBy Aiko AkihiroMay 3, 2023Updated:May 3, 2023No Comments2 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Bursa Malaysia Berhad, the Malaysian stock exchange, has reported a 17.4% decrease in its profit after tax and zakat for the first quarter ended 31 March 2023 (1Q2023).

    The exchange recorded a PAT of RM56.2 million in Q1 2023, down from RM68.0 million in the previous corresponding quarter (1Q2022).

    The decline was primarily due to a 13.4% decrease in the Securities Market’s operating revenue to RM100.0 million in 1Q2023 from RM115.6 million in 1Q2022.

    Additionally, the exchange saw a 10.6% increase in total operating expenses to RM80.2 million from RM72.5 million in 1Q2022 due to higher expenses on marketing, developmental and technology costs, and depreciation expenses.

    The exchange’s average daily trading value for On-Market Trades and Direct Business Trades decreased to RM2.3 billion from RM2.7 billion in 1Q2022, leading to a decrease in trading revenue.




    Meanwhile, the Derivatives Market’s operating revenue increased by 13.5% to RM28.3 million from RM24.9 million in 1Q2022, mainly due to the conference fees and exhibition-related income that increased to RM6.7 million from RM1.5 million in 1Q2022.

    Trading revenue in the Islamic Market increased by 18.5% to RM4.5 million in 1Q2023 from RM3.8 million in 1Q2022, while the data business segment saw a 5.7% increase in operating revenue.

    Bursa Malaysia CEO, Datuk Muhamad Umar Swift, attributed the decline in operating revenue to various macroeconomic factors and expressed optimism for Malaysia’s economic prospects amid external volatility.




    The exchange had 10 IPOs in 1Q2023, double the number of IPOs recorded in 1Q2022, demonstrating confidence that companies have in Bursa Malaysia as a valuable fundraising platform.

    The exchange plans to implement initiatives to improve operational and cost efficiency while introducing new offerings to enhance market vibrancy and attractiveness to investors.

    Bursa Malaysia aims to meet all five headline KPIs announced earlier in January 2023, provided no unforeseen circumstances arise during the year. – BusinessNewsAsia.com

    Bursa Malaysia Malaysia
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleMastercard to remove first-use PVC plastics from payment cards by 2028
    Next Article Dato’ Seri Dr Derek Goh Installed as President of Singapore Apex Teochew Association in presence of Deputy Prime Minister Mr Heng Swee Keat

    Related Posts

    Australian Made puts Singaporean approval centre-stage of its new campaign launch

    October 27, 2026

    AI Has No Single Answer About Your Brand: Why 43% of AI Answers Swap Leading Banks and Single Visibility Scores Fail Banking Leaders

    October 20, 2026

    TransNusa Celebrates Historic Milestone With Launch Off Maiden Melbourne-Bali Flight

    October 20, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Latest News

    • JCB Partners with Hanoi Metro to Introduce JCB Contactless Payment in Hanoi
    • Smokers in New Zealand are Still Waiting for a Promised Reform
    • GA-ASI and Saab Perform Advanced AEW Flight Testing on Uncrewed MQ-9B
    • SenesTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding
    • HKTDC Chairman deepens Hong Kong-GCC business ties with visit to Qatar
    • The 16th Asian Logistics, Maritime and Aviation Conference takes place on 16 and 17 November
    • DataTracks Extends Pillar Two Filing Support to Australia and New Zealand
    • Formerra Adjusts Transportation Surcharge Amid Continued Freight and Logistics Pressures
    • CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth
    • Hengrui Pharma Reports Steady Growth in the First Nine Months of 2026
    © 2026 BusinessNewsAsia.com

    Type above and press Enter to search. Press Esc to cancel.